Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers

• Hauptverfasser: Shun-Long Ou (Verfasst von), Jing Luo (Verfasst von), Hua Wei (Verfasst von), Xiao-Li Qin (Verfasst von), Qian Jiang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Evidence of efficacy and safety of programmed cell death 1 (PD-1) and programmed death ligand-1 (PD-L1) checkpoint inhibitors in oesophageal cancer (EC), gastric cancer (GC) and colorectal cancer (CRC) was inconsistent, obscuring their clinical application and decision-making. The aim of...